Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Total Liabilities & Equity Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Total Liabilities & Equity
$1.5B
CAGR 3-Years
14%
CAGR 5-Years
133%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Total Liabilities & Equity
CA$1.5m
CAGR 3-Years
-17%
CAGR 5-Years
10%
CAGR 10-Years
23%
Replicel Life Sciences Inc
XTSX:RP
Total Liabilities & Equity
CA$331.5k
CAGR 3-Years
-5%
CAGR 5-Years
23%
CAGR 10-Years
-20%
Innovotech Inc
XTSX:IOT
Total Liabilities & Equity
CA$1.1m
CAGR 3-Years
1%
CAGR 5-Years
36%
CAGR 10-Years
12%

See Also

What is Abcellera Biologics Inc's Total Liabilities & Equity?
Total Liabilities & Equity
1.5B USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Total Liabilities & Equity amounts to 1.5B USD.

What is Abcellera Biologics Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
133%

Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Abcellera Biologics Inc have been 14% over the past three years , 133% over the past five years .

Back to Top